Auxly Cannabis Group Inc. (CBWTF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Auxly Cannabis Group Inc. (CBWTF) trades at $0.13 with AI Score 54/100 (Grade B). Auxly Cannabis Group Inc. is a Canadian consumer packaged goods company focused on the cannabis market. Market cap: $179.62M, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for CBWTF: CBWTF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CBWTF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
CBWTF: 4/7 perspectives are bullish. Dominant signal: Ken Griffin bearish.
How is this calculated? →Auxly Cannabis Group Inc. (CBWTF) Healthcare & Pipeline Overview
Auxly Cannabis Group Inc. is a Canadian consumer-packaged goods company in the cannabis market, offering a diverse portfolio of cannabis products, including vapes, dried flower, concentrates, edibles, and topicals under brands like KOLAB PROJECT and Back Forty. They focus on recreational and wellness consumers in Canada.
What Is the Investment Thesis for CBWTF?
Auxly Cannabis Group Inc. presents a compelling investment thesis based on its established presence in the Canadian cannabis market and its focus on consumer-packaged goods. With a market capitalization of $179.62M and a price-to-earnings ratio of 6.4, the company demonstrates potential value. A gross margin of 59.5% and a profit margin of 31.1% indicate operational efficiency. Growth catalysts include expansion of its product lines and increased market penetration within Canada. Key risks include regulatory changes and competition from other cannabis producers. Investors should monitor the company's ability to maintain profitability and expand its market share in the evolving cannabis landscape.
Based on FMP financials and quantitative analysis
CBWTF Key Highlights
- Market capitalization of $179.62M indicates the company's current valuation in the market.
- P/E ratio of 6.4 suggests the stock may be undervalued compared to its earnings.
- Profit margin of 31.1% demonstrates strong profitability in the cannabis industry.
- Gross margin of 59.5% reflects efficient cost management in product manufacturing and sales.
- Beta of 1.20 indicates the stock is more volatile than the overall market.
Who Are CBWTF's Competitors?
CBWTF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AAWH Ascend Wellness Holdings, Inc. | $0.45 | -2.17% | $91.34M | 43 |
| BXPHF Botanix Pharmaceuticals Limited | $0.01 | +0.00% | $22.71M | 52 |
| HLTRF HLS Therapeutics Inc. | $3.00 | +0.00% | $93.82M | 48 |
| JUSHF Jushi Holdings Inc. | $0.45 | -3.20% | $89.86M | 41 |
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CBWTF's Key Strengths?
- Established brands in the Canadian market.
- Diverse product portfolio.
- Strong distribution network.
- Experienced management team.
What Are CBWTF's Weaknesses?
- Reliance on the Canadian market.
- Limited international presence.
- Exposure to regulatory changes.
- Competition from larger cannabis companies.
What Could Drive CBWTF Stock Higher?
- Expansion of product lines to include new cannabis-infused products.
- Increased market penetration through expanded distribution networks.
- Potential regulatory changes in the Canadian cannabis market.
- Strategic partnerships with retailers and distributors.
- Focus on developing and marketing high-margin cannabis products.
What Are the Key Risks for CBWTF?
- Financial-distress signal — its Altman Z-Score of -0.36 sits in the distress zone (elevated bankruptcy risk).
- Increasing competition from other cannabis companies in Canada.
- Changes in cannabis regulations that could impact operations.
- Fluctuations in cannabis prices affecting profitability.
- Negative consumer perception of cannabis products.
- Difficulty in securing financing for expansion plans.
What Are the Growth Opportunities for CBWTF?
- Expansion of Product Lines: Auxly has the opportunity to expand its product lines to include new and innovative cannabis products, such as edibles, beverages, and wellness products. The market for cannabis-infused products is growing rapidly, driven by increasing consumer demand for alternative consumption methods. By introducing new products, Auxly can attract new customers and increase its market share. The timeline for this growth opportunity is immediate and ongoing, as Auxly continuously innovates and introduces new products to the market.
- Increased Market Penetration: Auxly can increase its market penetration by expanding its distribution network and reaching new customers in Canada. The Canadian cannabis market is still relatively young, and there is significant potential for growth as more consumers become aware of and comfortable with cannabis products. By expanding its distribution network and increasing its marketing efforts, Auxly can reach new customers and increase its sales. The timeline for this growth opportunity is ongoing, as Auxly continues to expand its reach across Canada.
- Strategic Partnerships: Auxly can form strategic partnerships with other companies in the cannabis industry, such as retailers, distributors, and technology providers. These partnerships can help Auxly to expand its reach, improve its efficiency, and access new technologies. For example, Auxly could partner with a retailer to open new stores or with a technology provider to develop new cannabis products. The timeline for this growth opportunity is ongoing, as Auxly continuously seeks out new partnerships to enhance its business.
- International Expansion: Auxly can expand its operations into international markets, such as Europe and Latin America. The global cannabis market is growing rapidly, and there is significant potential for Auxly to expand its reach and increase its sales by entering new markets. However, international expansion also carries risks, such as regulatory uncertainty and competition from local players. The timeline for this growth opportunity is medium to long term, as Auxly carefully evaluates potential international markets and develops its expansion strategy.
- Focus on High-Margin Products: Auxly can focus on developing and marketing high-margin cannabis products, such as premium flower, concentrates, and edibles. These products typically command higher prices and generate greater profits than lower-margin products, such as commodity flower. By focusing on high-margin products, Auxly can improve its profitability and increase its shareholder value. The timeline for this growth opportunity is immediate and ongoing, as Auxly continuously evaluates its product portfolio and adjusts its strategy to focus on high-margin products.
What Opportunities Does CBWTF Have?
- Expansion into new product categories.
- Increased market penetration in Canada.
- Strategic partnerships with other companies.
- International expansion into new markets.
What Threats Does CBWTF Face?
- Increasing competition from other cannabis companies.
- Changes in cannabis regulations.
- Fluctuations in cannabis prices.
- Negative consumer perception of cannabis.
What Are CBWTF's Competitive Advantages?
- Established brands such as KOLAB PROJECT and BACK FORTY.
- Strong distribution network across Canada.
- Focus on product innovation and development.
What Does CBWTF Do?
Auxly Cannabis Group Inc., established in 1987 and formerly known as Cannabis Wheaton Income Corp. until June 2018, is a Canadian consumer packaged goods company operating within the cannabis market. Headquartered in Toronto, the company focuses on the development, manufacturing, and distribution of a diverse range of cannabis products targeted at both wellness and recreational consumers. Auxly's product portfolio includes various forms such as vape cartridges, dried flower, concentrates, chocolates, soft chews, oil drops, capsules, topicals, and hard candy. These products are marketed under several brands, including KOLAB PROJECT, Dosecann, BACK FORTY, and Foray. Auxly's business model centers around creating and distributing branded cannabis products to meet the evolving demands of the Canadian market. The company aims to establish a strong presence in the cannabis industry through product innovation, brand development, and strategic partnerships. With 388 employees, Auxly is committed to delivering high-quality cannabis products and experiences to its consumers.
What Products and Services Does CBWTF Offer?
- Develops and manufactures cannabis products.
- Distributes cannabis products across Canada.
- Offers vape cartridges, dried flower, and concentrates.
- Produces cannabis-infused chocolates and soft chews.
- Sells oil drops, capsules, and topicals.
- Markets products under the KOLAB PROJECT brand.
- Markets products under the Dosecann brand.
- Markets products under the BACK FORTY brand.
How Does CBWTF Make Money?
- Develops and manufactures cannabis products in-house and through partnerships.
- Distributes products through established retail channels across Canada.
- Focuses on branded cannabis products to build customer loyalty and market share.
What Industry Does CBWTF Operate In?
Auxly Cannabis Group Inc. operates within the rapidly evolving Canadian cannabis industry, which has seen significant growth since legalization. The market is characterized by increasing competition, evolving consumer preferences, and ongoing regulatory changes. Auxly competes with other cannabis producers and consumer packaged goods companies, including AAWH (AWH Corp), BKUH (Akanda Corp), BXPHF (Flora Growth Corp), HLTRF (Halo Collective Inc), and JUSHF (Jushi Holdings Inc). The company's success depends on its ability to differentiate its products, build strong brands, and navigate the complex regulatory landscape.
Who Are CBWTF's Key Customers?
- Recreational cannabis consumers in Canada.
- Wellness-focused consumers seeking cannabis-based products.
- Adults of legal age in provinces and territories where cannabis is legal.
Company Profile
Auxly Cannabis Group Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Toronto, CA. The company is led by CEO Hugo Alves. CBWTF has traded publicly since 2017.
ROE 20%Key Financial Metrics
Return on equity for Auxly Cannabis Group Inc. stands at 19.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 11.9%, showing how much profit it generates from its asset base. CBWTF trades at a trailing price-to-earnings ratio of 6.42, below the Healthcare sector average of ~23x. Its free cash flow yield is 13.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.23 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 13.8%, the inverse of the P/E and a quick read on earnings relative to price.
CBWTF Valuation & Market Position
With a $179.62M market cap, Auxly Cannabis Group Inc. sits in the micro-cap segment of the market. Relative to its peer group, CBWTF's quantitative score of 54/100 is roughly in line with the peer average of 51/100.
Quarterly Financial Performance: Auxly Cannabis Group Inc.
Revenue for Auxly Cannabis Group Inc. came in at $39.9M during Q1 2026. The company recorded net income of $3.5M, with diluted EPS of $0.00. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, CBWTF averaged $0.00 in diluted EPS.
F-Score 6/9Financial Health
Auxly Cannabis Group Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -0.36 places it in the distress zone, a signal of elevated financial risk.
FY2026 estForward Outlook
Wall Street analysts project Auxly Cannabis Group Inc. revenue of about $164.6M for fiscal 2026, with EPS near $0.01.
CBWTF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future, indicating that those closest to the business believe in its potential.
- Community sentiment has shifted positively, with increased discussions around product innovation and market expansion in the cannabis sector.
- The ongoing legalization trends in North America are creating new opportunities for growth, which Auxly is well-positioned to capitalize on.
- Recent partnerships and collaborations have enhanced brand visibility, fostering optimism among investors and consumers alike.
Bear Case
- Concerns about regulatory hurdles persist, as the cannabis industry continues to face scrutiny that could impact growth prospects.
- Social sentiment remains mixed, with some community members voicing skepticism about the company's ability to compete against larger players in the market.
- Recent earnings reports have shown slower-than-expected growth, leading to doubts about the company's operational efficiency and market strategy.
- Market perception has been affected by broader economic conditions, with investors wary of potential volatility in the cannabis sector.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $40M | $3M | $0.0022 |
| Q4 2025 | $40M | $943,000 | $0.0005 |
| Q3 2025 | $29M | $15M | $0.01 |
| Q2 2025 | $39M | $8M | $0.01 |
Based on FMP financials and quantitative analysis
CBWTF Latest News
-
Red White & Bloom Brands' Subsidiary, Emblem Cannabis Corporation, Assumes Debtor-In-Possession Financing for Ayurcann Following Assignment From Auxly Cannabis Group
globenewswire.com · Jun 3, 2026
-
TSX Penny Stock Highlights For May 2026
Yahoo! Finance: CBWTF News · May 26, 2026
-
Auxly to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
Yahoo! Finance: CBWTF News · May 26, 2026
-
Auxly Cannabis Group Inc (CBWTF) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...
Yahoo! Finance: CBWTF News · May 14, 2026
CBWTF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CBWTF.
Price Targets
Wall Street price target analysis for CBWTF.
CBWTF MoonshotScore
What does this score mean?
The MoonshotScore rates CBWTF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Red White & Bloom Brands' Subsidiary, Emblem Cannabis Corporation, Assumes Debtor-In-Possession Financing for Ayurcann Following Assignment From Auxly Cannabis Group
TSX Penny Stock Highlights For May 2026
Auxly to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
Auxly Cannabis Group Inc (CBWTF) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...
Leadership: Hugo Alves
CEO
Hugo Alves serves as the CEO of Auxly Cannabis Group Inc. His background includes extensive experience in the legal and cannabis industries. Prior to joining Auxly, Alves was a partner at Bennett Jones LLP, where he specialized in corporate law, with a focus on the cannabis sector. He has advised numerous cannabis companies on regulatory compliance, corporate governance, and capital markets transactions. Alves holds a law degree from Osgoode Hall Law School.
Track Record: Since becoming CEO, Hugo Alves has focused on streamlining Auxly's operations, expanding its product portfolio, and strengthening its market position in Canada. He has overseen the launch of new products, the expansion of the company's distribution network, and the implementation of cost-saving measures. Under his leadership, Auxly has achieved significant revenue growth and improved its profitability.
CBWTF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Auxly Cannabis Group Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, be undergoing restructuring, or face regulatory issues. Investing in companies on the OTC Other tier carries higher risks due to the lack of stringent listing requirements and potential for limited information availability compared to companies listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases information asymmetry.
- Lower trading volume can lead to price volatility.
- OTC listing may indicate financial or regulatory challenges.
- Potential for delisting if requirements are not met.
- Increased risk of fraud or manipulation compared to major exchanges.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review the company's OTC Markets profile for disclosures and alerts.
- Check for any regulatory actions or legal proceedings against the company.
- Consult with a financial advisor before investing.
- Understand the risks associated with investing in OTC stocks.
- Established operations in the Canadian cannabis market.
- Publicly traded status, even on the OTC market, provides some level of scrutiny.
- Audited financial statements (if available) enhance transparency.
- Experienced management team with a background in the cannabis industry.
- Partnerships with reputable companies in the cannabis sector.
CBWTF Healthcare Stock FAQ
What does Auxly Cannabis Group Inc. do?
Auxly Cannabis Group Inc. is a consumer packaged goods company in the Canadian cannabis market. They focus on developing, manufacturing, and distributing a variety of cannabis products for both recreational and wellness consumers. Their product range includes vape cartridges, dried flower, concentrates, edibles like chocolates and soft chews, oil drops, capsules, and topicals, all marketed under brands such as KOLAB PROJECT, Dosecann, BACK FORTY, and Foray. The company aims to provide diverse cannabis experiences to meet evolving consumer preferences in Canada.
What do analysts say about CBWTF stock?
Analyst coverage of Auxly Cannabis Group Inc. (CBWTF) is limited, reflecting its OTC listing and smaller market capitalization. Key valuation metrics include its P/E ratio of 6.4, which may suggest undervaluation, and its gross margin of 59.5%, indicating efficient operations. Growth considerations center on its ability to expand its market share in Canada, introduce new products, and manage regulatory risks. Investors should conduct their own due diligence and consider their risk tolerance before investing.
What are the main risks for CBWTF?
The main risks for Auxly Cannabis Group Inc. include increasing competition in the Canadian cannabis market, regulatory changes that could impact its operations, and fluctuations in cannabis prices that could affect its profitability. As an OTC-listed company, CBWTF also faces risks related to liquidity and information disclosure. Negative consumer perception of cannabis products and difficulty in securing financing for expansion plans are additional challenges. Investors should carefully consider these risks before investing in CBWTF.
What are the key growth opportunities for CBWTF in healthcare?
Auxly Cannabis Group Inc. can capitalize on growth opportunities within the healthcare sector by expanding its product lines to include cannabis-based wellness and therapeutic products. This includes developing formulations targeting specific health conditions, such as pain management, anxiety, and sleep disorders. Strategic partnerships with healthcare providers and research institutions can also facilitate the development and validation of these products. Additionally, Auxly can explore opportunities in the medical cannabis market, which often commands higher margins and greater regulatory support.
How does Auxly Cannabis Group Inc. navigate regulatory approval processes?
As a cannabis company operating in Canada, Auxly Cannabis Group Inc. navigates regulatory approval processes by adhering to the regulations set forth by Health Canada. This includes obtaining licenses for cultivation, processing, and distribution, as well as complying with strict quality control standards. Auxly also engages with regulatory bodies to stay informed about upcoming changes and to advocate for policies that support the growth of the cannabis industry. Furthermore, the company invests in research and development to ensure its products meet regulatory requirements and consumer safety standards.
What are the key factors to evaluate for CBWTF?
Auxly Cannabis Group Inc. (CBWTF) holds an AI score of 54/100 (moderate). P/E: 6.4x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does CBWTF data refresh on this page?
CBWTF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CBWTF's recent stock price performance?
Auxly Cannabis Group Inc. (CBWTF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brands in the Canadian market. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC data may be less reliable than exchange-listed data.
- AI analysis pending may provide additional insights in the future.